6794 — Unicocell Biomed Co Balance Sheet
0.000.00%
- TWD4.53bn
- TWD4.15bn
- TWD24.59m
Annual balance sheet for Unicocell Biomed Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 236 | 232 | 141 | 214 | 477 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.974 | 0.866 | 1.3 | 2.02 | 6.46 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 250 | 251 | 163 | 238 | 507 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 102 | 137 | 132 | 174 | 176 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 356 | 391 | 298 | 414 | 686 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 26.4 | 23.2 | 21.4 | 16.5 | 16.9 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 61.9 | 47.8 | 34.7 | 80.5 | 89.5 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 294 | 343 | 263 | 334 | 596 |
Total Liabilities & Shareholders' Equity | 356 | 391 | 298 | 414 | 686 |
Total Common Shares Outstanding |